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Correction of disturbances in lipid metabolism by diabetes remains a problem today. The aim of this work was to study the impact alkilselenonaftiridin (ASNR) on the dynamics of changes in the blood serum of levels lipoproteins of high (HDL), low (LDL) and very low (VLDL) density on the background of experimental streptozotocin-induced diabetes (DM). ASNR (180 mg / 100 g) were administered daily from the first day and 21 ht day experiment in two different groups. It is shown that diabetes leads to changes in the lipid composition of blood -reducing the level of HDL and, conversely, increased LDL and VLDL levels. Introduction ASNR positively influenced the change of levels these of lipoproteins. Especially in the case when ASNR administered on the first day of the experiment. In particular, the introduction ASNR the first day of the experiment prevents significant reduction of HDL levels, such as 8.3 and 9.9% on the 20 th and 40 th day of the experiment, respectively. ASNR prevents increasing of LDL levels on 13.3 and 10.4% on the 20 th and 40 th days experiment, respectively. Simultaneously, ASNR reduces the negative impact of DM on VLDL levels on 7.4, 11.1 and 21.4 % on the 20 th , 40 th and 60 th day experiment in accordance. However, the introduction of ASNR with 21 st day of the experiment has little effect on changes of levels lipoproteins, caused by the development of DM. Except reduction on 13.3 % the negative impact of diabetes on levels of VLDL on the 60 th day of the experiment. Thus, the introduction of ASNR positively influenced the change of levels lipoproteins of high, low and very low density on the background of experimental streptozotocininduced diabetes.
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Introduction. Diabetes mellitus (DM) is one of the most pressing biomedical problems, which is a priority the direction of national health systems [1] . In 2010 the total number of patients with all forms of diabetes in the world was about 239 million people. According to forecasts of the International Diabetes Federation (IDF), the number of patients with diabetes in the adult population (20-79 years) by 2030 will increase to 439 million [2] . The highest percentage of patients with diabetes mellitus belongs to the second type (80-95%) [3, 4] . Among the European population prevalence of diabetes is 7.8%. Most of them suffer from diabetes in Germany (10.2% of the population) and in Belgium (10% population), at least in the United Kingdom (4.2% of the population), significantly at least -in the Western Pacific Region [5, 6] . In Ukraine, according to Ministry of Health, about 1.5 million peoples are suffering with diabetes. It is estimated that among the inhabitants of different countries over 65 years, every 20th person suffers from diabetes, and this figure shows only those who know about the disease, and is registered in endocrinologist [7] . Diabetes accompanied by dangerous development of acute and chronic related disorders that lead to early disabilities and reducing life expectancy. Diabetes is a high risk for development blindness, renal failure, diabetic cardiomyopathy and encephalopathy [8] .
Concerning experimental studies, the aim was to studying diagnosis and treatment of diabetes, that is ЕКСПЕРИМЕНТАЛЬНА МЕДИЦИНА important and timely. The purpose of this work was to study the impact alkilselenonaftiridin on the dynamics of changes in the blood serum of levels lipoproteins of high, low and very low density on the background of experimental streptozotocin-induced diabetes.
Methods. The study was carried out in the autumn-winter period on 92 male rats of Wister weighing 220-280 g, which were kept in a standard diet of the vivarium of the department of anatomy and physiology of animal of «Lugansk National University Taras Shevchenko» [9] . Selection of rats for experiments was associated with the peculiarities of the methodological approach to the solution of the objectives and tasks. The number of experimental animals was determined according to the methods of statistical analysis [10] . The content and care of rats was carried out on compliance with the principles of bioethics and the «European Convention for the Protection of Vertebrate Animals», which are used for experimental and other scientific purposes (Strasbourg, 1985) , as well as the decisions of the «First National Congress on Bioethics» (Kiev, 2001) [11] .
The control group consisted of 23 rats. In the 69 research groups of animals was modeled experimental streptozotocin-induced diabetes. All animals of the experimental group were divided into three subgroups (23 rats) each one. The animals of the first sub -group (1-EG) simulated of streptozotocin diabetes (DM) without introducing Alkilselenonaftiridin -ASNR (number 7498352, «Brillstein Handbook»). The animals of second sub-group (2-EG) ASNR started to enter 21st days from the beginning of the experiment and the animals of the third experimental subgroups (3-EG) ASNR started to enter the first day of the experiment. Daily dose ASNR (180 mg /100 g) was calculated in accordance with M.A. Ansari et al. (2004) and N. Stanishovski (2008) [12, 13] .
The animals were injected intraperitoneally research group streptozotocin («Sigma-Aldrich», USA) at a dose of 50 mg/kg body weight in 0.1mol citrate buffer (pH=4.5) once. To confirm the playback diabetes in rats under administration streptozotocin photometrically determined glucose in the blood serum using glucoseoxydase method («Agat-Med», Ukraine) and whole blood using a glucometer «Glucofort» (Ukraine) and glucose in urine -by using diagnostic strips «Pentafan» («Lachema», Czech Republic).
Results and Discussion. (Fig. 1) . However, positive can be considered as mitigating negative impact of diabetes on the level of HDL. Namely, prevent a significant reduction in their levels on 8.3 and 9.9% on the 20th and 40th day experiment, respectively. We can conclude that the level of HDL in animals of all experimental subgroups dropped to 20 th day of the experiment and then increased until the 60th day experiment, exposure, but remained below the exposure control. The changes were more in the animals of 1st and 2nd experimental groups. Thus, the introduction of animals of ASNR with first day of the experiment (group 3-EG) reduces the negative impact of DM on levels of HDL. Simultaneously, the introduction of ASNR with 21st day (group 2-EG) has little effect on changes in levels of HDL, caused by the development of DM. The level of low-density lipoproteins (LDL) in the animals of the control group before the experiment was 0.24±0.05 mmol/l. On the 20th day of the experiment the level of LDL was within 0.23±0.05 mmol/l. On 40th day experiment was 0.26±0.06 mmol/l and on 60th day was 0.22±0.07 mmol/l. (Fig. 2) . In animals 3-EG LDL level before the experiment was 0.23±0.08 mmol/l, which in 1.04±0.231 times was lower than the control. On a 20 th day experiment LDL level increased to 0.30±0.12 mmol/l (in 1.30±0.23 times the exposure control) when P<0.05. On the 40 th and 60 th day of the experiment revealed a decrease in LDL level relative to 20 th day rate to 0.29±0.11 mmol/l (P<0.05) and 0.28±0.11 mmol/l (P< 0.05) in accordance, and remained above the exposure control in 1.12±0.17 and 1.27±0.37 times in accordance (Fig. 2) . Thus, the introduction of ASNR with first day of the experiment (3-EG) reduces the negative impact of DM on levels of LDL. Namely, prevent increase their level on 13.3 and 10.4% on the 20th and 40th day experiment, respectively. Simultaneously, the introduction of ASNR with 21st day (3-EG) has little effect on changes in levels of LDL, caused by the development of DM (Fig. 2) .
The level of very low density lipoproteins (VLDL) the animals of the control group before the experiment the VLDL level in serum was 0.34±0. (Fig. 3) . Thus in animals with experimental diabetes levels of VLDL in the blood serum versus control animals were significantly increased.
In comparison with the control animals in 2-EG animals, the VLDL baseline level was below in 1. Conclusions and prospects of further researches. Thus, it is shown that diabetes leads to changes in the lipid composition of blood -reducing the level of HDL and, conversely, increased LDL and VLDL levels [14, 15] . Introduction ASNR positively influenced the change of levels these of lipoproteins. Especially in the case when ASNR administered on the first day of the experiment (3-EG). In particular, the introduction ASNR the first day of the experiment prevents significant reduction of HDL levels, such as 8. 
